Unlabelled: The relevance of the study is due to the observed increase in antibiotic resistance of the main pathogens of chronic rhinosinusitis.

Objective: To evaluate the effectiveness of phage therapy in the complex treatment of exacerbations of chronic rhinosinusitis.

Material And Methods: The study included 55 patients with a verified diagnosis of chronic rhinosinusitis and a history of periodic exacerbations throughout the year, hospitalized at the St. Petersburg State Budgetary Institution «Elizabeth Hospital» from January 2022 to February 2023.Depending on the antimicrobial treatment received, patients were divided into groups that received an antibiotic or a bacteriophage.All patients underwent puncture of the maxillary sinuses. All patients in the first group taking an antibiotic, underwent sinus rinse with saline, and in the second group, a bacteriophage sinus rinse was used. Material from the first puncture of the maxillary sinuses was used to determine sensitivity to antibiotics and bacteriophages.

Results And Discussion: The average duration of treatment to positive outcome in the group receiving antibiotic therapy was 8±1.59 days, whereas in the group receiving bacteriophage therapy 7.69±1.35 days (=0.3008). There were no significant differences between groups in the average duration of treatment until a favorable outcome was achieved.

Conclusion: The high efficiency of phage therapy, the absence of its effect on the growth of antibiotic resistance allows us to recommend the use of bacteriophages in the treatment of chronic rhinosinusitis.

Download full-text PDF

Source
http://dx.doi.org/10.17116/otorino20238806148DOI Listing

Publication Analysis

Top Keywords

antibiotic resistance
12
phage therapy
8
chronic rhinosinusitis
8
puncture maxillary
8
maxillary sinuses
8
sinus rinse
8
average duration
8
duration treatment
8
group receiving
8
antibiotic
6

Similar Publications

A Comprehensive Review on Exploring the Potential of Phytochemicals and Biogenic Nanoparticles for the Treatment of Antimicrobial-Resistant Pathogenic Bacteria.

Curr Microbiol

January 2025

Molecular Biology Laboratory, Department of Microbiology, Science Campus, Alagappa University, Karaikudi, Tamil Nadu, 630003, India.

Antimicrobial resistance (AMR) is an escalating global health concern that results in approximately 700,000 deaths annually owing to drug-resistant infections. It compromises the effectiveness of conventional antibiotics, as well as fundamental medical procedures, such as surgery and cancer treatment. Phytochemicals, natural plant constituents, and biogenic nanoparticles synthesized through biological processes are pharmacological alternatives for supplementing or replacing traditional antibiotics.

View Article and Find Full Text PDF

The widespread use of antibiotics has led to the emergence of multidrug-resistant bacteria, which pose significant threats to animal health and food safety. Host defense peptides (HDPs) have emerged as promising alternatives because of their unique antimicrobial properties and minimal resistance induction. However, the high costs associated with HDP production and incorporation into animal management practices hinder their widespread application.

View Article and Find Full Text PDF

[An update of the Helicobacter pylori treatment: a Latin American Gastric Cancer, Helicobacter and Microbiota Study Group review].

Rev Gastroenterol Peru

January 2025

Departamento de Gastroenterología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

Helicobacter pylori (H. pylori) is the primary etiological agent of gastric adenocarcinoma, which affects over 60% of the global population, with a significant prevalence in Latin America. Given its impact on the affected population, it is crucial to understand the diagnostic tools available for detecting this infection.

View Article and Find Full Text PDF

[Treatment of Helicobacter pylori infection in the era of antibiotic resistance. What do we know?].

Rev Gastroenterol Peru

January 2024

Unidad Motilidad Digestiva, Clínica San Felipe, Lima, Perú; Servicio de Gastroenterología Clínica Ricardo Palma, Lima, Perú; Universidad Peruana Cayetano Heredia, Lima, Perú.

View Article and Find Full Text PDF

Antimicrobial-resistant bacteria are particularly prevalent in Southeast Asia, mainly due to inadequate infection prevention and control (IPC) and the widespread and uncontrolled use of antibiotics. Pakistan is the third largest low-middle-income country (LMIC) user of antibiotics. Antibiotic consumption increased by 65%, from 800 million to 1.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!